
Vaccines 2016-2022: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Description
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Vaccines: The World Market analyzes the revenues for vaccines used in humans to prevent various types of disease. The report provides a comprehensive revenue summary, including revenue growth of vaccines vs. pharmaceuticals, 2013-2022; global market for vaccines by type, pediatric vs. adult, 2013-2022; global vaccines revenues by vaccine type, 2013-2022 (pediatric: combinations, hepatitis, HIB, MMR, pneumococcal, poliovirus, varicella, others; adult: cervical cancer, hepatitis, influenza, pneumococcal, travel - DT - misc., total); global vaccines revenues by geographic region, 2013-2022 (U.S., North America / Caribbean, South America, EU, Japan, India, China, rest of world, total); major companies’ shares of the global vaccine market, 2015; 2015 global vaccines revenues, by leading competitors; major companies’ shares of the global pediatric vaccine market, 2015; and major companies’ shares of the global adult vaccine market, 2015.
This market review concentrates on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. Further, the report analyzes the developing and current pediatric preventive vaccines market, as well as examining in detail the adult preventative vaccines market. GlaxoSmithKline, Merck & Co., Pfizer, and Sanofi Pasteur are among the dominant companies whose vaccine offerings are reviewed in-depth.
Vaccines: The World Market analyzes the revenues for vaccines used in humans to prevent various types of disease. The report provides a comprehensive revenue summary, including revenue growth of vaccines vs. pharmaceuticals, 2013-2022; global market for vaccines by type, pediatric vs. adult, 2013-2022; global vaccines revenues by vaccine type, 2013-2022 (pediatric: combinations, hepatitis, HIB, MMR, pneumococcal, poliovirus, varicella, others; adult: cervical cancer, hepatitis, influenza, pneumococcal, travel - DT - misc., total); global vaccines revenues by geographic region, 2013-2022 (U.S., North America / Caribbean, South America, EU, Japan, India, China, rest of world, total); major companies’ shares of the global vaccine market, 2015; 2015 global vaccines revenues, by leading competitors; major companies’ shares of the global pediatric vaccine market, 2015; and major companies’ shares of the global adult vaccine market, 2015.
This market review concentrates on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. Further, the report analyzes the developing and current pediatric preventive vaccines market, as well as examining in detail the adult preventative vaccines market. GlaxoSmithKline, Merck & Co., Pfizer, and Sanofi Pasteur are among the dominant companies whose vaccine offerings are reviewed in-depth.
Table of Contents
260 Pages
- THE GLOBAL VACCINES INDUSTRY
- THEMARKET
- ISSUES AND TRENDS
- Global Morbidity of Vaccine Preventable Diseases in 1990 vs 2014
- A BRIEF HISTORY: THE DEVELOPMENT OF VACCINES
- THE IMMUNE RESPONSE
- MECHANISM OF ACTION
- TYPES OF VACCINES
- VACCINE APPROVAL PROCESS
- INTRODUCTION
- CHILDHOOD IMMUNIZATION IN THE UNITED STATES
- PEDIATRIC VACCINE PRODUCTS
- PEDIATRIC VACCINES IN DEVELOPMENT
- COST OF VACCINES IN THE UNITED STATES
- THEWORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES
- INTRODUCTION
- ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES
- GLOBAL INFLUENZA SURVEILLANCE PROGRAM
- RECOMMENDATIONS FOR ADULT IMMUNIZATIONS
- ADULT VACCINE PRODUCTS
- ADULT VACCINES IN DEVELOPMENT
- THEWORLD MARKET FOR ADULT PREVENTIVE VACCINES
- TRENDS DRIVING THE VACCINES MARKET
- MARKET SIZE AND FORECAST
- VACCINE SAFETY
- PRICING PRESSURE
- VACCINE SHORTAGES
- PREVENTING PANDEMICS
- VACCINES AND BIOTERRORISM
- STIMULATING VACCINE DEVELOPMENT
- INNOVATIONS IN VACCINE DELIVERY SYSTEMS
- INNOVATIONS IN VACCINE PRODUCTION
- BAVARIAN NORDIC A/S
- BHARAT BIOTECH
- CRUCELL /JOHNSON &JOHNSON
- CSL LIMITED
- EMERGENT BIOSOLUTIONS
- GLAXOSMITHKLINE
- HAWAII BIOTECH
- MEDIMMUNE
- MERCK&CO., INC
- MYMETICS
- OPEXA THERAPEUTICS
- PFIZER
- SANOFI PASTEUR
- Company Directory
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.